Skip to main content
SleepCited

Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico.

Flor Cristina Ortiz Rios, Itzel Guadalupe Dávila Ruiz, Elisa Sacal Dumani
Case Report Drugs in context 2022 6 件の引用
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D36188636'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究タイプ
Case Reports
サンプルサイズ
3
対象集団
Patients with anxiety disorders in Mexico
介入
Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. None
比較対照
None
主要アウトカム
Anxiety symptom improvement
効果の方向
Positive
バイアスリスク
High

Abstract

Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need arises to develop new pharmacological treatments for these patients. This paper has the primary objective of evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases.

要約

Evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases is evaluated.

Used In Evidence Reviews

Similar Papers